Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FM
Subjects: ESQUIZOFRENIA (COMPLICAÇÕES), PLAQUETAS SANGUÍNEAS, ENZIMAS (DEFICIÊNCIA), FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Aline Siqueira et al. Lower phosphorylated glycogen synthase kinase 3B levels in platelets of patients with schizophrenia: Increment by olanzapine treatment. European Archives of Psychiatry and Clinical Neuroscience, v. 265, n. 2, p. 167-170, 2015Tradução . . Disponível em: https://doi.org/10.1007/s00406-014-0505-9. Acesso em: 30 set. 2024.APA
Ferreira, A. S., Raposo, N. R. B., Sallet, P. C., van de Bilt, M. T., Vieira, R. M., Gattaz, W. F., & Talib, L. L. (2015). Lower phosphorylated glycogen synthase kinase 3B levels in platelets of patients with schizophrenia: Increment by olanzapine treatment. European Archives of Psychiatry and Clinical Neuroscience, 265( 2), 167-170. doi:10.1007/s00406-014-0505-9NLM
Ferreira AS, Raposo NRB, Sallet PC, van de Bilt MT, Vieira RM, Gattaz WF, Talib LL. Lower phosphorylated glycogen synthase kinase 3B levels in platelets of patients with schizophrenia: Increment by olanzapine treatment [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 2): 167-170.[citado 2024 set. 30 ] Available from: https://doi.org/10.1007/s00406-014-0505-9Vancouver
Ferreira AS, Raposo NRB, Sallet PC, van de Bilt MT, Vieira RM, Gattaz WF, Talib LL. Lower phosphorylated glycogen synthase kinase 3B levels in platelets of patients with schizophrenia: Increment by olanzapine treatment [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2015 ; 265( 2): 167-170.[citado 2024 set. 30 ] Available from: https://doi.org/10.1007/s00406-014-0505-9